Business founded in 2005 has won contracts to track global variants worth £144m from UK government
Oxford Nanopore, whose Covid-19 technology was snapped up by the UK government and used to track variants of the virus globally, plans to float on the London stock exchange in one of the biggest London debuts this year.
The company, a startup spun out from Oxford University, was valued at £2.4bn at a fundraising round in May. It is aiming to reduce its losses to break even in the next five years.